American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 621-625 , September 2008

Light Chain Deposition Disease After Renal Transplantation

  • Sekiko Taneda, MD

      Affiliations

    • Department of Pathology, Kidney Center, Tokyo Women's Medical University, Tokyo
    • Corresponding Author InformationAddress correspondence to Sekiko Taneda, MD, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
    • ,
  • Kazuho Honda, MD

      Affiliations

    • Department of Pathology, Kidney Center, Tokyo Women's Medical University, Tokyo
    • ,
  • Shigeru Horita, MS

      Affiliations

    • Department of Pathology, Kidney Center, Tokyo Women's Medical University, Tokyo
    • ,
  • Ichiro Koyama, MD

      Affiliations

    • Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo
    • ,
  • Satoshi Teraoka, MD

      Affiliations

    • Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo
    • ,
  • Hideaki Oda, MD

      Affiliations

    • Department of Pathology, Kidney Center, Tokyo Women's Medical University, Tokyo
    • ,
  • Yutaka Yamaguchi, MD

      Affiliations

    • Department of Pathology, Kashiwa Hospital, Jikei University, Chiba, Japan

Received 10 September 2007 ,Accepted 13 February 2008.

References 

  1. Colombat M, Stern M, Groussard O, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006;173:777–780
  2. Randall RE, Williamson WC, Mullinax F, Tung MY, Still WJ. Manifestations of systemic light chain deposition. Am J Med. 1976;60:293–299
  3. Ganeval D, Noel LH, Preud'homme JL, Droz D, Grunfeld JP. Light-chain deposition disease: Its relation with AL-type amyloidosis. Kidney Int. 1984;26:1–9
  4. Walker F, Bear RA. Renal transplantation in light-chain multiple myeloma. Am J Nephrol. 1983;3:34–37
  5. Gerlag PG, Koene RA, Berden JH. Renal transplantation in light chain nephropathy: Case report and review of the literature. Clin Nephrol. 1986;25:101–104
  6. Ecder T, Tbakhi A, Braun WE, et al. De novo light-chain deposition disease in a cadaver renal allograft. Am J Kidney Dis. 1996;28:461–465
  7. Howard AD, Moore J, Tomaszewski MM. Occurrence of multiple myeloma three years after successful renal transplantation. Am J Kidney Dis. 1987;10:147–150
  8. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1990;4:53–62
  9. Sheil AGR. Cancer in Dialysis and Transplant Patients (Kidney Transplantation). In: Philadelphia, PA: Saunders; 1994;p. 390–400
  10. Leung N, Lager DJ, Gertz MA, et al. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis. 2004;43:147–153
  11. Radl J, Valentijn RM, Haaijman JJ, Paul LC. Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunopathol. 1985;37:98–102
  12. Markowitz GS. Dysproteinemia and the kidney. Adv Anat Pathol. 2004;11:49–63
  13. Korbet SM, Schwartz MM. Multiple myeloma. J Am Soc Nephrol. 2006;17:2533–2545
  14. Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease (Light-chain, heavy-chain, and light- and heavy-chain deposition diseases). Hematol Oncol Clin North Am. 1999;13:1235–1248
  15. Dussol B, Tsimaratos M, Lerda D, et al. [Viral hepatitis C and membranoproliferative glomerulonephritis in a renal transplant patient]. Nephrologie. 1995;16:223–226
  16. Rosenstock JL, Markowitz GS, Valeri AM, et al. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney Int. 2003;63:1450–1461
  17. Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG. Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy. Nephrol Dial Transplant. 1996;11:837–842
  18. Alpers CE, Rennke HG, Hopper J, Biava CG. Fibrillary glomerulonephritis: An entity with unusual immunofluorescence features. Kidney Int. 1987;31:781–789
  19. Korbet SM, Rosenberg BF, Schwartz MM, Lewis EJ. Course of renal transplantation in immunotactoid glomerulopathy. Am J Med. 1990;89:91–95
  20. Calls Ginesta J, Torras A, Ricart MJ, et al. Fibrillary glomerulonephritis and pulmonary hemorrhage in a patient with renal transplantation. Clin Nephrol. 1995;43:180–183
  21. Rao KV, Hafner GP, Crary GS, Anderson WR, Crosson JT. De novo immunotactoid glomerulopathy of the renal allograft: Possible association with cytomegalovirus infection. Am J Kidney Dis. 1994;24:97–103
  22. Hartmann A, Holdaas H, Fauchald P, et al. Fifteen years' experience with renal transplantation in systemic amyloidosis. Transpl Int. 1992;5:15–18
  23. Pasternack A, Ahonen J, Kuhlback B. Renal transplantation in 45 patients with amyloidosis. Transplantation. 1986;42:598–601
  24. Sherif AM, Refaie AF, Sobh MA, et al. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis. 2003;42:370–375

 Originally published online as doi:10.1053/j.ajkd.2008.02.370 on June 12, 2008.

PII: S0272-6386(08)00770-1

doi: 10.1053/j.ajkd.2008.02.370

American Journal of Kidney Diseases
Volume 52, Issue 3 , Pages 621-625 , September 2008

Article Tools

* Image Usage & Resolution